Contrast-enhanced MR Angiography of the renal arteries: blinded multicenter crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine
. Radiology 2005 Feb;234(2):399-408.
Nephrogenic systemic fibrosis after gadopentetate dimeglumine
exposure: case series of 36 patients.
The conventional method is to infuse ultrasound gel or oral gadopentetate dimeglumine
and polyethylene glycol to fill the rectum.
contrast (Magnevist; Schering, Berlin, and Germany) in all the patients was administered intravenously at a weight-based dosing of 0.2 ml/kg with a bolus injection rate of 2 ml/sec using an automatic injector, which was followed by a 20-ml saline bolus injection.
(Magnevist[R], Bayer Pharma, Gd-DTPA) is a MRI contrast agent that diffuses exclusively into the extracellular space of the liver .
When necessary, magnetic resonance imaging (MRI) was performed with liver specific MRI contrast agents, including gadopentetate dimeglumine
(Magnevist[R]; Bayer Pharmaceuticals) and Gadoxetate disodium (Primovist[R], Bayer Pharmaceuticals) used at the discretion of the radiologist.
Data acquisition was initiated simultaneously with intravenous injection gadopentetate dimeglumine
(Magnevist, Bayer Healthcare, Leverkusen; 0.1mmol/kg at 6 mL/s) followed by a 20 mL saline flush, injected at a rate of 2 mL/s.
enhanced sagittal and axial (SE) T1W (TR, 450-600 msec; TE, 15-20 msec) images were obtained in all patients of intradural tumours.
Patients in this study were injected with intravenous gadopentetate dimeglumine
during imaging of their elbows.
He subsequently underwent a CT scan of the abdomen and pelvis with oral contrast (OMNIPAQUE 300 milliliters), a radiographic bone survey, and a contrast (MAGNEVIST (Gadopentetate Dimeglumine
) 15 milliliters) enhanced MR of the brain and orbits.
Kaewlai, "Acute adverse reactions to gadopentetate dimeglumine
and gadobenate dimeglumine: experience with 32,659 injections," American Journal of Roentgenology, vol.
The second was a 363-patient Pan-Asian Phase III trial with 120 Japanese patients, which indicated non-inferiority of gadobutrol-enhanced MR images of the body (breast, heart, abdomen, kidney, pelvis and extremity) to those obtained through the use of gadopentetate dimeglumine